Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β2-agonist via dry-powder inhalers and pressurized metered-dose inhalers

Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β2-agonist via dry-powder inhalers and pressurized metered-dose inhalers

Eric T Wittbrodt,1 Lauren A Millette,1 Kristin A Evans,2 Machaon Bonafede,2 Joseph Tkacz,2 Gary T Ferguson3 1Medical Affairs, AstraZeneca, Wilmington, DE, USA; 2Life Sciences, Value-Based Care, IBM Watson Health, Cambridge, MA, USA; 3Pulmonary Research Institute of Southeast Michigan, Farmington Hi...

Full description

Bibliographic Details
Main Authors: Wittbrodt ET, Millette LA, Evans KA, Bonafede M, Tkacz J, Ferguson GT
Format: Article
Language:English
Published: Dove Medical Press 2018-12-01
Series:International Journal of COPD
Subjects:
chronic obstructive pulmonary disease
inhaler
inhaled corticosteroid
long-acting beta-agonist
utilization
costs
Online Access:https://www.dovepress.com/differences-in-health-care-outcomes-between-postdischarge-copd-patient-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/differences-in-health-care-outcomes-between-postdischarge-copd-patient-peer-reviewed-article-COPD

Similar Items